BTLS announced a new partnership with 21st.BIO to realise biocontrol production at commercially competitive costs. Existing partnership with Novonesis will be concluded with BTLS looking for new (a) new partner(s) for commercialization down the line.Most importantly, Evoca NG approval timeline is not affected. 2026 will be a year of manufacturing optimization + (limited) additional field trials, followed by ~2 years of regulatory review of the supplementary dossier with approval estimated aroun ....
